Urinary excretion of epsilondA is not predictive of cancer development: a prospective nested case-control study

Peter R Hillestrøm, Kristiina Nyssönen, Tomi-Pekka Tuomainen, Eero Pukkala, Jukka T Salonen, Henrik E Poulsen

3 Citations (Scopus)

Abstract

Human biomonitoring of the lipid peroxidation DNA modification 1,N6-ethenodeoxyadenosine (epsilondA) excreted into urine is thought to be a potential marker for oxidative stress-related DNA damage and human cancer. We have tested this hypothesis in a prospective, nested case-control study. During the years 1984-1989, 24-h urines were collected from 1956 men in the Kuopio Ischaemic Heart Disease (KIHD) Risk Factor Study. epsilondA concentrations were measured by LC-MS/MS in 24-h urine samples from 47 men with cancer diagnosed at follow up until 2001 and from 31 cancer free smoking-matched control subjects. Odds ratio for having higher than control median epsilon dA excretion rate and cancer, estimated by binary logistic regression, was 0.73 (95% CI 0.29-1.80, p = 0.49). In this study, the urinary excretion of epsilondA provides no additional prediction of cancer development in males after controlling for smoking.

Original languageEnglish
JournalFree Radical Research
Volume39
Issue number1
Pages (from-to)51-3
Number of pages3
ISSN1071-5762
DOIs
Publication statusPublished - Jan 2005

Keywords

  • Adult
  • Body Mass Index
  • Body Weight
  • Case-Control Studies
  • Chromatography, Liquid
  • DNA/metabolism
  • DNA Adducts
  • DNA Damage
  • Deoxyadenosines/urine
  • Humans
  • Lipid Peroxidation
  • Logistic Models
  • Male
  • Mass Spectrometry
  • Middle Aged
  • Neoplasms/diagnosis
  • Odds Ratio
  • Oxidative Stress
  • Prospective Studies
  • Risk
  • Risk Factors
  • Smoking
  • Time Factors

Fingerprint

Dive into the research topics of 'Urinary excretion of epsilondA is not predictive of cancer development: a prospective nested case-control study'. Together they form a unique fingerprint.

Cite this